Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation

Jin Sun Cho, Shin Hyung Kim, Seokyung Shin, Hui Nam Pak, Shi Joon Yang, Young Jun Oh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Sympathetic hyperactivation during tracheal intubation prolongs the QT interval and increases the risk of arrhythmias. We investigated if dexmedetomidine pretreatment affected autonomic nervous system balance and QT intervals during intubation. Sixty-six patients were randomized to receive 1.0 g/kg fentanyl (group F, n 22), 0.5 g/kg dexmedetomidine (group D0.5, n 22), or 1.0 g/kg dexmedetomidine (group D1.0, n 22) before induction. Autonomic nervous system balance was assessed by the ratio of low-frequency/high-frequency (LF/HF) power for heart rate variability at baseline (T0), before intubation (T1), and after intubation (T2). QT intervals were corrected by the Bazett's formula (QT c) and compared at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The LF/HF ratio was higher after intubation compared with that at T0 in group F (P < 0.001). There were no significant changes in groups D0.5 and D1.0. The LF/HF ratio was significantly higher in group F compared with those in groups D0.5 and D1.0 after intubation (7.9 vs. 2.1 and 2.5; P < 0.001). The heart rate was increased for 3 minutes after intubation in group F, whereas only for 1 minute after intubation in groups D0.5 and D1.0, compared with that at baseline. More patients in group F had QT c greater than 440 ms compared with that in group D0.5 or D1.0 (8 vs. 1 and 2; P 0.005) at 1 minute after intubation. In contrast to 1.0 g/kg fentanyl, pretreatment with 0.5 or 1.0 g/kg dexmedetomidine suppressed sympathetic hyperactivity and attenuated QT c prolongation during intubation.

Original languageEnglish
Pages (from-to)e369-e376
JournalAmerican Journal of Therapeutics
Volume23
Issue number2
DOIs
Publication statusPublished - 2016 Mar 1

Fingerprint

Dexmedetomidine
Intubation
Heart Rate
Hemodynamics
Autonomic Nervous System
Fentanyl
Cardiac Arrhythmias

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Cho, Jin Sun ; Kim, Shin Hyung ; Shin, Seokyung ; Pak, Hui Nam ; Yang, Shi Joon ; Oh, Young Jun. / Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation. In: American Journal of Therapeutics. 2016 ; Vol. 23, No. 2. pp. e369-e376.
@article{5b9fddec141a4f5392da33eaa6960619,
title = "Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation",
abstract = "Sympathetic hyperactivation during tracheal intubation prolongs the QT interval and increases the risk of arrhythmias. We investigated if dexmedetomidine pretreatment affected autonomic nervous system balance and QT intervals during intubation. Sixty-six patients were randomized to receive 1.0 g/kg fentanyl (group F, n 22), 0.5 g/kg dexmedetomidine (group D0.5, n 22), or 1.0 g/kg dexmedetomidine (group D1.0, n 22) before induction. Autonomic nervous system balance was assessed by the ratio of low-frequency/high-frequency (LF/HF) power for heart rate variability at baseline (T0), before intubation (T1), and after intubation (T2). QT intervals were corrected by the Bazett's formula (QT c) and compared at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The LF/HF ratio was higher after intubation compared with that at T0 in group F (P < 0.001). There were no significant changes in groups D0.5 and D1.0. The LF/HF ratio was significantly higher in group F compared with those in groups D0.5 and D1.0 after intubation (7.9 vs. 2.1 and 2.5; P < 0.001). The heart rate was increased for 3 minutes after intubation in group F, whereas only for 1 minute after intubation in groups D0.5 and D1.0, compared with that at baseline. More patients in group F had QT c greater than 440 ms compared with that in group D0.5 or D1.0 (8 vs. 1 and 2; P 0.005) at 1 minute after intubation. In contrast to 1.0 g/kg fentanyl, pretreatment with 0.5 or 1.0 g/kg dexmedetomidine suppressed sympathetic hyperactivity and attenuated QT c prolongation during intubation.",
author = "Cho, {Jin Sun} and Kim, {Shin Hyung} and Seokyung Shin and Pak, {Hui Nam} and Yang, {Shi Joon} and Oh, {Young Jun}",
year = "2016",
month = "3",
day = "1",
doi = "10.1097/MJT.0000000000000074",
language = "English",
volume = "23",
pages = "e369--e376",
journal = "American Journal of Therapeutics",
issn = "1075-2765",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation. / Cho, Jin Sun; Kim, Shin Hyung; Shin, Seokyung; Pak, Hui Nam; Yang, Shi Joon; Oh, Young Jun.

In: American Journal of Therapeutics, Vol. 23, No. 2, 01.03.2016, p. e369-e376.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation

AU - Cho, Jin Sun

AU - Kim, Shin Hyung

AU - Shin, Seokyung

AU - Pak, Hui Nam

AU - Yang, Shi Joon

AU - Oh, Young Jun

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Sympathetic hyperactivation during tracheal intubation prolongs the QT interval and increases the risk of arrhythmias. We investigated if dexmedetomidine pretreatment affected autonomic nervous system balance and QT intervals during intubation. Sixty-six patients were randomized to receive 1.0 g/kg fentanyl (group F, n 22), 0.5 g/kg dexmedetomidine (group D0.5, n 22), or 1.0 g/kg dexmedetomidine (group D1.0, n 22) before induction. Autonomic nervous system balance was assessed by the ratio of low-frequency/high-frequency (LF/HF) power for heart rate variability at baseline (T0), before intubation (T1), and after intubation (T2). QT intervals were corrected by the Bazett's formula (QT c) and compared at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The LF/HF ratio was higher after intubation compared with that at T0 in group F (P < 0.001). There were no significant changes in groups D0.5 and D1.0. The LF/HF ratio was significantly higher in group F compared with those in groups D0.5 and D1.0 after intubation (7.9 vs. 2.1 and 2.5; P < 0.001). The heart rate was increased for 3 minutes after intubation in group F, whereas only for 1 minute after intubation in groups D0.5 and D1.0, compared with that at baseline. More patients in group F had QT c greater than 440 ms compared with that in group D0.5 or D1.0 (8 vs. 1 and 2; P 0.005) at 1 minute after intubation. In contrast to 1.0 g/kg fentanyl, pretreatment with 0.5 or 1.0 g/kg dexmedetomidine suppressed sympathetic hyperactivity and attenuated QT c prolongation during intubation.

AB - Sympathetic hyperactivation during tracheal intubation prolongs the QT interval and increases the risk of arrhythmias. We investigated if dexmedetomidine pretreatment affected autonomic nervous system balance and QT intervals during intubation. Sixty-six patients were randomized to receive 1.0 g/kg fentanyl (group F, n 22), 0.5 g/kg dexmedetomidine (group D0.5, n 22), or 1.0 g/kg dexmedetomidine (group D1.0, n 22) before induction. Autonomic nervous system balance was assessed by the ratio of low-frequency/high-frequency (LF/HF) power for heart rate variability at baseline (T0), before intubation (T1), and after intubation (T2). QT intervals were corrected by the Bazett's formula (QT c) and compared at baseline, before intubation, and 1, 2, and 3 minutes after intubation. The LF/HF ratio was higher after intubation compared with that at T0 in group F (P < 0.001). There were no significant changes in groups D0.5 and D1.0. The LF/HF ratio was significantly higher in group F compared with those in groups D0.5 and D1.0 after intubation (7.9 vs. 2.1 and 2.5; P < 0.001). The heart rate was increased for 3 minutes after intubation in group F, whereas only for 1 minute after intubation in groups D0.5 and D1.0, compared with that at baseline. More patients in group F had QT c greater than 440 ms compared with that in group D0.5 or D1.0 (8 vs. 1 and 2; P 0.005) at 1 minute after intubation. In contrast to 1.0 g/kg fentanyl, pretreatment with 0.5 or 1.0 g/kg dexmedetomidine suppressed sympathetic hyperactivity and attenuated QT c prolongation during intubation.

UR - http://www.scopus.com/inward/record.url?scp=84900352626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900352626&partnerID=8YFLogxK

U2 - 10.1097/MJT.0000000000000074

DO - 10.1097/MJT.0000000000000074

M3 - Article

C2 - 24832388

AN - SCOPUS:84900352626

VL - 23

SP - e369-e376

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 2

ER -